Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06305169
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-12
First Post:
2024-02-28
Brief Title:
Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric Cancer
Sponsor:
Sandwell West Birmingham Hospitals NHS Trust
Organization:
Sandwell West Birmingham Hospitals NHS Trust
Study Overview
Official Title:
Measuring the Negative Predictive Value and Specificity of Serum Biomarkers in Gastric Cancer Along With Creating a Predictive Model for the Identification of Patients That Need Urgent Endoscopy
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Atrophic gastritis where the cells of the stomach lining change is the single most important precursor condition for gastric cancer Helicobacter pylori a bacteria which causes infection in the stomach is the most important causative agent of inflammation of the stomach and subsequent atrophic gastritis
The difficulty with diagnosing patients with gastric cancer is that a lot of patients will suffer from heartburn and pain around the stomach but very few of those will have gastric cancer This makes it difficult for GPs to know who to refer for further testing as the current cancer referral criteria are very broad
To reduce the need for invasive diagnostic methods such as endoscopy where a flexible tube with camera is inserted into the gullet and stomach via the mouth a commercially available blood test GastroPanel designed to measure the levels of certain key stomach hormones to detect atrophic gastritis has been developed It is extremely rare for gastric cancer to develop without there first being gastric atrophy
A real word study is needed assess the performance of this blood test in a group of patients referred via an urgent cancer pathway for endoscopy in the UK Scoring systems have been created to help us triage referrals to endoscopy in those with difficulty swallowing but no similar score is available for those presenting with other upper abdominal symptoms By using this blood test as well as collecting patient information we hope to create an improved referral criteria for those needing investigation for gastric cancer
The difficulty with diagnosing patients with gastric cancer is that a lot of patients will suffer from heartburn and pain around the stomach but very few of those will have gastric cancer This makes it difficult for GPs to know who to refer for further testing as the current cancer referral criteria are very broad
To reduce the need for invasive diagnostic methods such as endoscopy where a flexible tube with camera is inserted into the gullet and stomach via the mouth a commercially available blood test GastroPanel designed to measure the levels of certain key stomach hormones to detect atrophic gastritis has been developed It is extremely rare for gastric cancer to develop without there first being gastric atrophy
A real word study is needed assess the performance of this blood test in a group of patients referred via an urgent cancer pathway for endoscopy in the UK Scoring systems have been created to help us triage referrals to endoscopy in those with difficulty swallowing but no similar score is available for those presenting with other upper abdominal symptoms By using this blood test as well as collecting patient information we hope to create an improved referral criteria for those needing investigation for gastric cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None